Buonvino S, Arciero I, Martinelli E, Seliktar D, Melino S
Mater Today Bio. 2023; 23:100862.
PMID: 38046276
PMC: 10689286.
DOI: 10.1016/j.mtbio.2023.100862.
Tarle M, Raguz M, Muller D, Luksic I
Int J Mol Sci. 2023; 24(6).
PMID: 36982894
PMC: 10056291.
DOI: 10.3390/ijms24065816.
Betzler A, Strobel H, Kors T, Ezic J, Lesakova K, Pscheid R
Cancers (Basel). 2023; 15(1).
PMID: 36612306
PMC: 9818583.
DOI: 10.3390/cancers15010310.
Wu Q, Zheng Z, Zhang J, Piao Z, Xin M, Xiang X
Front Oncol. 2022; 12:862751.
PMID: 35494000
PMC: 9046701.
DOI: 10.3389/fonc.2022.862751.
Xu P, Zhao R, Zhang C, Zhang Q, Wang Y, Zhu J
Cell Death Discov. 2021; 7(1):386.
PMID: 34897285
PMC: 8665927.
DOI: 10.1038/s41420-021-00777-6.
The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages.
Li Z, Liu F, Kirkwood K
Oral Oncol. 2020; 103:104591.
PMID: 32058294
PMC: 7136140.
DOI: 10.1016/j.oraloncology.2020.104591.
Cisplatin effect on head and neck squamous cell carcinoma cells is modulated by ERK1/2 protein kinases.
Bostan M, Petrica-Matei G, Ion G, Radu N, Mihaila M, Hainarosie R
Exp Ther Med. 2019; 18(6):5041-5051.
PMID: 31798724
PMC: 6880449.
DOI: 10.3892/etm.2019.8139.
Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway.
Chen Y, Chen X, Ding X, Wang Y
Mol Med Rep. 2019; 20(4):3317-3325.
PMID: 31432165
PMC: 6755195.
DOI: 10.3892/mmr.2019.10562.
Mechanisms shaping the role of ERK1/2 in cellular senescence (Review).
Zou J, Lei T, Guo P, Yu J, Xu Q, Luo Y
Mol Med Rep. 2018; 19(2):759-770.
PMID: 30535440
PMC: 6323238.
DOI: 10.3892/mmr.2018.9712.
Fibroblast growth factor receptor 3-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition.
Ban M, Byeon H, Yang Y, An S, Kim J, Kim J
Cancer Sci. 2018; 109(12):3816-3825.
PMID: 30343534
PMC: 6272115.
DOI: 10.1111/cas.13839.
Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma.
Guimaraes E, de Carli M, Sperandio F, Hanemann J, Pereira A
Med Oral Patol Oral Cir Bucal. 2015; 20(6):e657-63.
PMID: 26449430
PMC: 4670244.
DOI: 10.4317/medoral.20601.
Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.
Wangsa D, Chowdhury S, Ryott M, Gertz E, Elmberger G, Auer G
Int J Cancer. 2015; 138(1):98-109.
PMID: 26175310
PMC: 4823771.
DOI: 10.1002/ijc.29691.
Impact of warm ischemia on phosphorylated biomarkers in head and neck squamous cell carcinoma.
Tower J, Lingen M, Seiwert T, Langerman A
Am J Transl Res. 2014; 6(5):548-57.
PMID: 25360219
PMC: 4212929.
Cyclin D1 expression is correlated with cell differentiation and cell proliferation in oral squamous cell carcinomas.
Ohnishi Y, Watanabe M, Wato M, Tanaka A, Kakudo K, Nozaki M
Oncol Lett. 2014; 7(4):1123-1127.
PMID: 24944679
PMC: 3961451.
DOI: 10.3892/ol.2014.1880.
Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S, Kotta-Loizou I, Klijanienko J, Giaginis C, Alexandrou P, Dana E
Tumour Biol. 2014; 35(7):6455-65.
PMID: 24682903
DOI: 10.1007/s13277-014-1853-9.
Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients.
Yang Z, Guan B, Men T, Fujimoto J, Xu X
In Vivo. 2013; 27(4):473-84.
PMID: 23812217
PMC: 3849809.
Immunohistochemical study of β-catenin and functionally related molecular markers in tongue squamous cell carcinoma and its correlation with cellular proliferation.
Yun X, Wang L, Cao L, Okada N, Miki Y
Oncol Lett. 2012; 1(3):437-443.
PMID: 22966322
PMC: 3436458.
DOI: 10.3892/ol_00000077.
Decreased mRNA expression levels of base excision repair (BER) pathway genes is associated with enhanced Ki-67 expression in HNSCC.
Mahjabeen I, Chen Z, Zhou X, Kayani M
Med Oncol. 2012; 29(5):3620-5.
PMID: 22798271
DOI: 10.1007/s12032-012-0300-2.
Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.
Huang S, Cheng S, Chuang W, Chen I, Liao C, Wang H
World J Surg Oncol. 2012; 10:40.
PMID: 22336657
PMC: 3312822.
DOI: 10.1186/1477-7819-10-40.
Salivary analysis of oral cancer biomarkers.
Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I
Br J Cancer. 2009; 101(7):1194-8.
PMID: 19789535
PMC: 2768098.
DOI: 10.1038/sj.bjc.6605290.